ArticleJournal of surgical case reports2026
Early experience with a composite ovine forestomach matrix graft in chronic lower extremity wounds: a multi-center retrospective case series.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic wounds place a significant burden on patients and healthcare. A newer outpatient treatment is a composite bioscaffold that contains ovine forestomach matrix and hyaluronic acid (OFM-HA). This multi-center retrospective case series investigated OFM-HA in the treatment of lower extremity chronic wounds. Medical records of 10 patients were reviewed and patient and wound characteristics were documented. Time to 50% percent area reduction (%PAR), time to closure, and complications were evaluated. Patients were primarily elderly with several comorbidities. The mean time to 50% PAR was 3.2 ± 2.3 weeks, and the mean time to closure was 9.9 ± 5.1 weeks. Patients received a median of 4 (IQR: 2, 5) applications. No complications or recurrences occurred. OFM-HA was effective and safe to treat complex lower extremity chronic wounds in the outpatient setting. Moreover, OFM-HA proved to be a durable material, with full closure requiring few applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.